Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2023 | 03-2023 | 09-2022 | 03-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,092 | 34,610 | 53,854 | 31,583 | 29,552 |
| Other current assets | 5,210 | 796 | 5,524 | 1,273 | 6,263 |
| TOTAL | $23,302 | $40,081 | $59,378 | $36,490 | $35,815 |
| Non-Current Assets | |||||
| PPE Net | 1,940 | 2,370 | 2,699 | 3,047 | 3,325 |
| Intangibles | 394 | 397 | 400 | 403 | 405 |
| TOTAL | $2,334 | $2,767 | $3,099 | $3,450 | $3,730 |
| Total Assets | $25,636 | $42,848 | $62,477 | $39,940 | $39,545 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,731 | 16,526 | 15,731 | N/A | N/A |
| Accounts payable and accrued liabilities | 913 | 2,181 | 2,792 | 2,201 | 1,789 |
| TOTAL | $21,007 | $26,303 | $27,205 | $17,321 | $9,592 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 0 | 14,971 | 14,247 |
| TOTAL | $1,274 | $1,619 | $1,951 | $17,239 | $16,821 |
| Total Liabilities | $22,281 | $27,922 | $29,156 | $34,560 | $26,413 |
| Shareholders' Equity | |||||
| Common Shares | 3,349 | 3,349 | 3,349 | 2,753 | 2,753 |
| Retained earnings | -113,827 | -101,935 | -81,313 | -73,980 | -64,226 |
| Other shareholders' equity | 14,331 | 14,010 | 11,783 | 10,307 | 8,305 |
| TOTAL | $3,355 | $14,926 | $33,321 | $5,380 | $13,132 |
| Total Liabilities And Equity | $25,636 | $42,848 | $62,477 | $39,940 | $39,545 |